208 related articles for article (PubMed ID: 14997058)
121. Hot flashes refractory to HRT and SSRI therapy but responsive to gabapentin therapy.
Guttuso T
J Pain Symptom Manage; 2004 Mar; 27(3):274-6. PubMed ID: 15038336
[TBL] [Abstract][Full Text] [Related]
122. Comparison of Gabapentin with Estrogen for treatment of hot flashes in post-menopausal women.
Allameh Z; Rouholamin S; Valaie S
J Res Pharm Pract; 2013 Apr; 2(2):64-9. PubMed ID: 24991606
[TBL] [Abstract][Full Text] [Related]
123. Pathophysiology and management of hot flashes.
Dalal S; Zhukovsky DS
J Support Oncol; 2006; 4(7):315-20, 325. PubMed ID: 16892692
[TBL] [Abstract][Full Text] [Related]
124. Putting evidence into practice: evidence-based interventions for hot flashes resulting from cancer therapies.
Kaplan M; Mahon S; Cope D; Keating E; Hill S; Jacobson M
Clin J Oncol Nurs; 2011 Apr; 15(2):149-57. PubMed ID: 21444282
[TBL] [Abstract][Full Text] [Related]
125. The efficacy of nonestrogenic therapy to hot flashes in cancer patients under hormone manipulation therapy: a systematic review and meta-analysis.
Yamaguchi N; Okajima Y; Fujii T; Natori A; Kobayashi D
J Cancer Res Clin Oncol; 2013 Oct; 139(10):1701-7. PubMed ID: 23974271
[TBL] [Abstract][Full Text] [Related]
126. Management of hot flashes in breast cancer survivors and men with prostate cancer.
Stearns V
Curr Oncol Rep; 2004 Jul; 6(4):285-90. PubMed ID: 15161582
[TBL] [Abstract][Full Text] [Related]
127. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S).
Lancet; 1994 Nov; 344(8934):1383-9. PubMed ID: 7968073
[TBL] [Abstract][Full Text] [Related]
128. A systematic review of non-hormonal treatments of vasomotor symptoms in climacteric and cancer patients.
Drewe J; Bucher KA; Zahner C
Springerplus; 2015; 4():65. PubMed ID: 25713759
[TBL] [Abstract][Full Text] [Related]
129. Treating recurrent postmenopausal vasomotor symptoms in a patient with a positive family history for breast cancer.
Leong C; Lake J
Consult Pharm; 2015 Jan; 30(1):38-44. PubMed ID: 25591030
[TBL] [Abstract][Full Text] [Related]
130. Management of hot flashes in patients who have breast cancer with venlafaxine and clonidine: a randomized, double-blind, placebo-controlled trial.
Boekhout AH; Vincent AD; Dalesio OB; van den Bosch J; Foekema-Töns JH; Adriaansz S; Sprangers S; Nuijen B; Beijnen JH; Schellens JH
J Clin Oncol; 2011 Oct; 29(29):3862-8. PubMed ID: 21911720
[TBL] [Abstract][Full Text] [Related]
131. What can be done about hot flushes after treatment for breast cancer?
Kontos M; Agbaje OF; Rymer J; Fentiman IS
Climacteric; 2010 Feb; 13(1):4-21. PubMed ID: 20067430
[TBL] [Abstract][Full Text] [Related]
132. Nonhormonal therapies for menopausal hot flashes: systematic review and meta-analysis.
Nelson HD; Vesco KK; Haney E; Fu R; Nedrow A; Miller J; Nicolaidis C; Walker M; Humphrey L
JAMA; 2006 May; 295(17):2057-71. PubMed ID: 16670414
[TBL] [Abstract][Full Text] [Related]
133. Hormonal and nonhormonal treatment of vasomotor symptoms.
Krause MS; Nakajima ST
Obstet Gynecol Clin North Am; 2015 Mar; 42(1):163-79. PubMed ID: 25681847
[TBL] [Abstract][Full Text] [Related]
134. Low-dose estradiol and the serotonin-norepinephrine reuptake inhibitor venlafaxine for vasomotor symptoms: a randomized clinical trial.
Joffe H; Guthrie KA; LaCroix AZ; Reed SD; Ensrud KE; Manson JE; Newton KM; Freeman EW; Anderson GL; Larson JC; Hunt J; Shifren J; Rexrode KM; Caan B; Sternfeld B; Carpenter JS; Cohen L
JAMA Intern Med; 2014 Jul; 174(7):1058-66. PubMed ID: 24861828
[TBL] [Abstract][Full Text] [Related]
135. Pharmacist services provided in general practice clinics: a systematic review and meta-analysis.
Tan EC; Stewart K; Elliott RA; George J
Res Social Adm Pharm; 2014; 10(4):608-22. PubMed ID: 24161491
[TBL] [Abstract][Full Text] [Related]
136. Potential role of gabapentin and extended-release gabapentin in the management of menopausal hot flashes.
Yadav M; Volkar J
Int J Gen Med; 2013; 6():657-64. PubMed ID: 23950657
[TBL] [Abstract][Full Text] [Related]
137. Non-hormonal management of vasomotor symptoms.
Sassarini J; Lumsden MA
Climacteric; 2013 Aug; 16 Suppl 1():31-6. PubMed ID: 23848489
[TBL] [Abstract][Full Text] [Related]
138. Androgen deprivation therapy: evidence-based management of side effects.
Ahmadi H; Daneshmand S
BJU Int; 2013 Apr; 111(4):543-8. PubMed ID: 23351025
[TBL] [Abstract][Full Text] [Related]
139. Management of menopause-associated vasomotor symptoms: Current treatment options, challenges and future directions.
Pachman DR; Jones JM; Loprinzi CL
Int J Womens Health; 2010 Aug; 2():123-35. PubMed ID: 21072305
[TBL] [Abstract][Full Text] [Related]
140.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
